The Alliance for Safe Biologic Medicines (ASBM) is a Washington-area advocacy coalition focused on biologic and biosimilar medicines, with an emphasis on patient safety, pharmacovigilance, and clear product identification in biosimilars policy.
Biosimilars regulation, biologic naming and labeling, substitution and interchangeability policy, pharmacovigilance, patient safety, and related FDA and health-care regulatory issues.
Primarily funded by contributions and grants from industry and related stakeholders, including pharmaceutical and biotechnology interests.
Steering committee members and affiliated groups have included Alliance for Patient Access, American Academy of Dermatology, American Autoimmune Related Diseases Association, Association of Clinical Research Organizations, Colon Cancer Alliance, Global Colon Cancer Association, Global Healthy Living Foundation, Health HIV, Hepatitis Foundation International, International Cancer Advocacy Network, Kidney Cancer Association, National Psoriasis Foundation, and ZeroCancer; prominent ASBM figures have included John Desser, Sheila Walcoff, Christina Beato, Doug Badger, and Michael Reilly.
non-profit advocacy organization (social welfare organization, 501(c)(4))
